The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 5, 2012, Pages 725-730

  Higashi, Chizuka ^a   Saji, Chiaki ^b   Yamada, Koji ^b   Kagawa, Hiroki ^b   Ohga, Rie ^a   Taira, Takahiro ^a   Fujimuro, Masahiro ^a,c  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Heat shock protein 90; Kaposi's sarcoma associated herpesvirus; Nuclear factor kappa B; Primary effusion lymphoma

Indexed keywords

CASPASE; CASPASE 3; CASPASE 7; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; RADICICOL; TANESPIMYCIN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; LYMPHOMA CELL; NONHUMAN; PRIMARY EFFUSION LYMPHOMA; PROGENY; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VIRUS REPLICATION;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BENZOQUINONES; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 8, HUMAN; HSP90 HEAT-SHOCK PROTEINS; HUMANS; I-KAPPA B PROTEINS; LACTAMS, MACROCYCLIC; LYMPHOMA, PRIMARY EFFUSION; MACROLIDES; NF-KAPPA B; PHOSPHORYLATION; SARCOMA, KAPOSI; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 84861205536     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.725     Document Type: Article

References (22)

1. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U.S.A., 93, 14862-14867 (1996).
2. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, Knowles DM. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood, 88, 645-656 (1996).
3. Drexler HG, Uphoff CC, Gaidano G, Carbone A. Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia, 12, 1507-1517 (1998).
4. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266, 1865-1869 (1994).
5. Fujimuro M, Wu FY, ApRhys C, Kajumbula H, Young DB, Hayward GS, Hayward SD. A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med., 9, 300-306 (2003).
6. Fujimuro M, Hayward SD, Yokosawa H. Molecular piracy: manipulation of the ubiquitin system by Kaposi's sarcoma-associated herpesvirus. Rev. Med. Virol., 17, 405-422 (2007).
7. Chaudhary PM, Jasmin A, Eby MT, Hood L. Modulation of the NF-κB pathway by virally encoded death effector domains-containing proteins. Oncogene, 18, 5738-5746 (1999).
8. Keller SA, Schattner EJ, Cesarman E. Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood, 96, 2537-2542 (2000).
9. Hinz M, Broemer M, Arslan SC, Otto A, Mueller EC, Dettmer R, Scheidereit C. Signal responsiveness of IkappaB kinases is determined by Cdc37-assisted transient interaction with Hsp90. J. Biol. Chem., 282, 32311-32319 (2007).
10. Saji C, Higashi C, Niinaka Y, Yamada K, Noguchi K, Fujimuro M. Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells. Biochem. Biophys. Res. Commun., 415, 573-578 (2011).
11. Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C, Collins M. KSHV vFLIP binds to IKK-gamma to activate IKK. J. Cell Sci., 116, 3721-3728 (2003).
12. Wen KW, Damania B. Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1. Oncogene, 29,3532-3544 (2010).
13. Fujimuro M, Liu J, Zhu J, Yokosawa H, Hayward SD. Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen. J. Virol., 79, 10429-10441 (2005).
14. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell, 91, 243-252 (1997).
15. Qin Z, DeFee M, Isaacs JS, Parsons C. Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV. Virology, 403, 92-102 (2010).
16. Defee MR, Qin Z, Dai L, Toole BP, Isaacs JS, Parsons CH. Extracellular Hsp90 serves as a co-factor for NF-κB activation and cellular pathogenesis induced by an oncogenic herpesvirus. Am. J. Cancer Res., 1, 687-700 (2011).
17. Wen KW, Damania B. Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1. Oncogene, 29, 3532-3544 (2010).
18. Keller SA, Hernandez-Hopkins D, Vider J, Ponomarev V, Hyjek E, Schattner EJ, Cesarman ENF. NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood, 107, 3295-3302 (2006).
19. Dabaghmanesh N, Matsubara A, Miyake A, Nakano K, Ishida T, Katano H, Horie R, Umezawa K, Watanabe T. Transient inhibition of NF-kappaB by DHMEQ induces cell death of primary effusion lymphoma without HHV-8 reactivation. Cancer Sci., 100, 737-746 (2009).
20. Solit DB, Chiosis G. Development and application of Hsp90 inhibitors. Drug Discov. Today, 13, 38-43 (2008).
21. Haque M, Davis DA, Wang V, Widmer I, Yarchoan R. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia. J. Virol., 77, 6761-6768 (2003).
22. Cohen A, Brodie C, Sarid R. An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus. J. Gen. Virol., 87, 795-802 (2006).